![](/img/cover-not-exists.png)
Effect of Angiotensin Converting Enzyme Inhibitor or Beta-Blocker Use on the Benefit of Fixed-Dose Combined Isosorbide Dinitrate/Hydralazine in the African-American Heart Failure Trial
Jalal K. Ghali, Anne L. Taylor, S. William Tam, Michael L. Sabolinski, Manuel Worcel, Jay N. CohnVolume:
12
Year:
2006
Language:
english
DOI:
10.1016/j.cardfail.2006.06.273
File:
PDF, 50 KB
english, 2006